Serotypes and antimicrobial susceptibilities of 1033 pneumococci isolated from children in Greece during 2001-2004

Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
I ParaskakisNational Surveillance Network for Pneumococcal Resistance

Abstract

Pneumococci (n = 1033) isolated in the major paediatric hospitals of Athens during 2001-2004 from children with invasive infections (n = 186), non-invasive infections (n = 641) and healthy carriers (n = 206) were studied. The most prevalent serotypes were serotypes 14 (44.6%), 19F (43.5%) and 6B (22.8%) in invasive, non-invasive and carriage isolates, respectively. Among invasive isolates, the potential coverage by the seven-valent conjugate vaccine was 75.3%. Resistance rates to penicillin, amoxycillin, cefotaxime, erythromycin, co-trimoxazole, clindamycin, tetracycline and chloramphenicol were 44.6%, 2.7%, 1.2%, 43.6%, 43.5%, 12.4%, 34.7% and 5.9%, respectively. The M-phenotype accounted for 68.0% of the erythromycin-resistant isolates. All isolates were susceptible to ofloxacin.

References

Mar 3, 1999·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I ParaskakisD A Kafetzis
Jan 5, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W P HausdorffG R Siber
Jan 26, 2000·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·M TsoliaT Karpathios
Jun 2, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G A SyrogiannopoulosN G Beratis
Nov 30, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A PantostiP Mastrantonio
Feb 28, 2002·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Georgia KouppariDimitris Kafetzis
May 11, 2002·The Journal of Antimicrobial Chemotherapy·Marja PihlajamäkiUNKNOWN Finnish Study Group for Antimicrobial Resistance
May 29, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter C Appelbaum
Jun 22, 2002·The Journal of Antimicrobial Chemotherapy·Dieter Adam
Aug 31, 2002·Journal of Clinical Microbiology·Maria Rosario AmezagaHamish McKenzie
Apr 2, 2003·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J MaugeinB Poirier
Dec 4, 2003·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J-W DecousserP-Y Allouch
Jun 25, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·I SerranoUNKNOWN Portuguese Surveillance Group for the Study of Respiratory Pathogens
Sep 10, 2004·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J OteoUNKNOWN Spanish EARSS Group
Nov 9, 2004·The Journal of Antimicrobial Chemotherapy·Nienke BruinsmaUNKNOWN European Antimicrobial Resistance Surveillance System (EARSS)
Jan 15, 2005·The Journal of Antimicrobial Chemotherapy·Monica MonacoAnnalisa Pantosti

❮ Previous
Next ❯

Citations

Jul 10, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S MarakiE Galanakis
Oct 13, 2012·BMC Infectious Diseases·Ioanna N GriveaGeorge A Syrogiannopoulos
Dec 14, 2007·Diagnostic Microbiology and Infectious Disease·George L DaikosVassiliki P Syriopoulou
Jun 2, 2007·International Journal of Antimicrobial Agents·G PoulakouUNKNOWN Hellenic Study Group for the Susceptibility of Streptococcus pneumoniae
Mar 21, 2007·International Journal of Antimicrobial Agents·Georgina Tzanakaki, Paola Mastrantonio
Oct 20, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A MavroidiL S Tzouvelekis
Oct 16, 2009·Expert Opinion on Pharmacotherapy·M KleinU Koedel
Apr 17, 2018·The Journal of Antimicrobial Chemotherapy·D TorumkuneyI Morrissey

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Related Papers

International Journal of Antimicrobial Agents
G PoulakouHellenic Study Group for the Susceptibility of Streptococcus pneumoniae
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
M SouliH Giamarellou
© 2022 Meta ULC. All rights reserved